RECRUITING

Time Restricted Feeding, Muscle, and Metabolism

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Effective nutrition strategies for combatting and/or preventing obesity still need to be identified. This has been the case despite the numerous and different approaches that have been taken. Potential targets for combatting/preventing obesity have been identified, but long-term solutions have not emerged. This study uses time restricted feeding to study the role of dietary protein in obesity prevention and/or treatment. The objectives are to determine the role of skeletal muscle mass as a driver of energy-sensing mechanisms and peripheral signals that regulate appetite and energy intake in overweight and obese adults and to determine the effects of protein timing on muscle mass to regulate appetite and energy intake in overweight and obese adults.

Official Title

Time Restricted Feeding Intervention for Muscle and Metabolic Health (TRIMM)

Quick Facts

Study Start:2021-06-13
Study Completion:2025-05-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04949451

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:25 Years to 50 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * Resides in Northwest Arkansas
  2. * Age 25-50 years
  3. * BMI \> 25
  4. * All ethnicities
  5. * Female and male
  1. * Food allergies
  2. * Pregnant or breastfeeding
  3. * Dietary restrictions (e.g. vegetarian, vegan, etc.)
  4. * Trying to lose weight in last 3 months
  5. * Pre-existing health conditions related to obesity (e.g. cardiovascular disease, diabetes, hypertension)
  6. * Prescription medications related to heart disease or type 2 diabetes
  7. * Fear of needles
  8. * Smoker or vaping
  9. * Currently taking protein supplements or other nutritional supplements which may interfere with study outcomes
  10. * Consumes \>4 alcoholic beverages per week

Contacts and Locations

Study Contact

Jamie Baum, PhD
CONTACT
479-575-4474
baum@uark.edu

Study Locations (Sites)

University of Arkansas
Fayetteville, Arkansas, 72704
United States

Collaborators and Investigators

Sponsor: University of Arkansas, Fayetteville

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-06-13
Study Completion Date2025-05-30

Study Record Updates

Study Start Date2021-06-13
Study Completion Date2025-05-30

Terms related to this study

Additional Relevant MeSH Terms

  • Overweight
  • Obesity